Intravenous and oral MDL 17043 (A new inotrope-vasodilator agent) in congestive heart failure: Hemodynamic and clinical evaluation in 38 patients-Reference-Cited by-同舟云学术

Intravenous and oral MDL 17043 (A new inotrope-vasodilator agent) in congestive heart failure: Hemodynamic and clinical evaluation in 38 patients

Published:1984-11 Issue:5 Volume:4 Page:884-889
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Kereiakes Dean,Chatterjee Kanu,Parmley William W.,Atherton Beverley,Curran Deirdre,Kereiakes Anne,Spangenberg Robert

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference14 articles.

1. Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure;Chatterjee;J Am Coll Cardiol,1983

2. Acute hemodynamic response to vasodilator therapy in congestive heart failure;Ribner;Prog Cardiovasc Dis,1982

3. The role of vasodilator therapy in heart failure;Chatterjee;Prog Cardiovasc Dis,1977

4. Hemodynamic assessment of amrinone;Benotti;N Engl J Med,1978

5. Biochemical studies on the mechanism of cardiotonic activity of RMI 17043 (1,3 dihydro 4 methyl-5-[4-(methylthio)-benzoyl]-2H-imidizole-2-one) (abstr);Kariya;Fed Proc,1982

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PDE3-inhibitor enoximone prevented mechanical ventilation in patients with SARS-CoV-2 pneumonia;Experimental Lung Research;2021-02-05

2. Phosphodiesterase 3 and 4 Inhibition: Facing a Bright Future in Asthma Control;Asthma Diagnosis and Management - Approach Based on Phenotype and Endotype;2018-07-04

3. Phosphodiesterase type III inhibitors;Meyler's Side Effects of Drugs;2016

4. Enoximone;Meyler's Side Effects of Drugs;2016

5. Emergency Treatment of Status Asthmaticus With Enoximone;Survey of Anesthesiology;2015-08